# Letter to the Editor Regarding ‘Overall Survival with Apalutamide Versus Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer’

**Authors:** Martin W. Schoen, Tito Fojo

PMC · DOI: 10.1007/s12325-025-03434-x · 2025-11-28

## Full-text entities

- **Diseases:** Castration (MESH:D064129), Prostate Cancer (MESH:D011471)
- **Chemicals:** Apalutamide (MESH:C572045), Enzalutamide (MESH:C540278)

---
Source: https://tomesphere.com/paper/PMC12858555